Quantcast
Home > Quotes > NXTM
NXTM

NxStage Medical Inc. Common Stock (NXTM) Quote & Summary Data

$28.261
*  
0.049
0.17%
Get NXTM Alerts
*Delayed - data as of Aug. 16, 2018 14:33 ET  -  Find a broker to begin trading NXTM now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    NXTM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 28.27 / $ 28.30
1 Year Target
30
Today's High / Low
$ 28.54 / $ 28.21
Share Volume
230,962
50 Day Avg. Daily Volume
395,951
Previous Close
$ 28.31
52 Week High / Low
$ 29.37 / $ 22.70
Market Cap
1,879,269,089
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.22
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.24

Intraday Chart

Shares Traded

Share Volume:
230,962
50 Day Avg. Daily Volume:
395,951

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.22

Trading Range

The current last sale of $28.261 is 24.50% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 28.54 $ 29.37
 Low: $ 28.21 $ 22.70

ETFs with NXTM as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
0.57% iShares U.S. Medical Devices ETF (IHI) +27.04 (14.93%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Our Company NxStage Medical, Inc. is a medical technology company that develops, manufactures and markets innovative products and services for patients suffering from chronic or acute kidney failure. We also operate a small number of NxStage Kidney Care dialysis centers, independently and in some instances as joint ventures, that treat end-stage renal disease (ESRD) patients directly. Our primary product, the System One, was designed to satisfy an unmet clinical need for a system capable of delivering the therapeutic flexibility and clinical benefits of traditional dialysis machines in a smaller, portable, easy-to-use form that can be used by healthcare professionals and trained lay users alike in a variety of settings, including patient homes, as well as more traditional care settings such as hospitals and dialysis centers.  ... More ...  


Risk Grade

Where does NXTM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 28.34
Open Date:
Aug. 16, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info